AstraZeneca expands its portfolio through Alexion Pharmaceuticals buyout

By Nikita Chaurasia  | Date: 2020-12-14

AstraZeneca expands its portfolio through Alexion Pharmaceuticals buyout

British-Swedish multinational pharmaceutical company, AstraZeneca Plc, has reportedly finalized a deal worth USD 39 billion with Alexion Pharmaceuticals Inc., an American pharmaceutical company which specializes in rare disease.

Sources close to the matter stated that the planned cash-and-stock acquisition will help in boosting the development of treatments for immunological and uncommon blood disorders in AstraZeneca’s portfolio, which has always focused on cancer treatments instead. The transaction would also allow AstraZeneca to generate over USD 500 million in the upcoming three years, the company claimed.

The recent development allowed Alexion’s share to be valued at USD 175, a 45% premium to the final price on closing. Sources confirmed that the deal will also establish AstraZeneca a spot among the top 10 drug makers of the world.

Prior to the pandemic, AstraZeneca had showcased 70% growth in value in the last three years as it rolled out cancer drugs such as Tagrisso, Imfinzi, and Lynparza. However, it has been relatively cash-poor since the recent past, and thus will gain benefits from Alexion’s growing business.

During the agreement, every Alexion shareholder will obtain 2.1234 AstaZeneca American depository share and cash worth USD 60. The acquisition will be funded by the British drug maker with USD around 17.5 billion funding provided by Goldman Sachs Group Inc., JPMorgan Chase & Co., and Morgan Stanley.

Geoffrey Porges, an analyst at SVB Leerink, reportedly stated that despite the premium, the price is relatively attractive for AstraZeneca and could further draw out additional offers. Moreover, shareholders of Alexion could hold out for USD 200 per share or seek for a higher cash portion.

A fee of around USD 1.2 billion is included in the contract if Alexion decides to sell itself to another bidder, while AstraZeneca will potentially face a USD 1.4 billion penalty. The deal is scheduled to close in the third quarter of 2021, and Alexion shareholders will own over 15% of the combined companies, sources confirmed.

Source- https://theprint.in/world/astrazeneca-plans-post-covid-growth-with-39-billion-deal-with-alexion-pharmaceuticals/565886/

 

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Zomato net loss triples to USD 46 million despite 75% jump in revenues

Zomato net loss triples to USD 46 million despite 75% jump in revenues

By Nikita Chaurasia

Indian food delivery giant Zomato Limited has reported a net loss worth USD 46 million in Q4 of FY2021-22 despite witnessing a 75% growth in revenue to USD 156 million as opposed to USD 89 million it earlier recorded during the fourth quarter of the ...

Facebook-owner Meta to share more data on political advertisements

Facebook-owner Meta to share more data on political advertisements

By Nikita Chaurasia

Facebook-parent Meta Platforms Inc has recently announced that it would provide additional data from its public ad database regarding the targeting decisions made by publishers running social and political-issue advertising. As a part of the expan...

Massachusetts finds first 2022 monkeypox case in the United States

Massachusetts finds first 2022 monkeypox case in the United States

By Nikita Chaurasia

The Massachusetts Department of Public Health has recently reported the first case of a rare infection called monkeypox in a man who recently visited Canada. According to Boston’s public department, the identified case is no threat to the pu...

Russia denies plans of blocking YouTube & cutting off from the internet

Russia denies plans of blocking YouTube & cutting off from the internet

By Nikita Chaurasia

The Digital Development Minister of Russia has reportedly stated that the country is not planning to block Google’s video streaming platform YouTube as such a move would affect its users and will therefore be avoided.  It is worth notin...

Indian food delivery giant Swiggy to buy Dineout from Times Internet

Indian food delivery giant Swiggy to buy Dineout from Times Internet

By Nikita Chaurasia

Swiggy, an Indian food delivery giant, has recently announced an agreement with Times Internet to buy Dineout, a dining and restaurant technology platform. Swiggy will use the acquisition to enter the dining out (non-delivery) market, where it will c...